Entering text into the input field will update the search result below

Organogenesis, CytomX top healthcare gainers; Karyopharm Bright Health lead losers' pack

Mar. 02, 2022 10:01 AM ETAMGN, MNKD, AHPIQ, ICPT, KPTI, CTMX, XFOR, ORGO, HOOK, BHGBy: Ravikash, SA News Editor1 Comment

stock market

hxdbzxy/iStock via Getty Images

  • Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%.
  • Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Group (NYSE:BHG) -23%. ChemoCentryx (NASDAQ:CCXI) -21%. HOOKIPA Pharma (NASDAQ:HOOK) -20%. Intercept Pharmaceuticals (NASDAQ:ICPT) -15%.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.